All In MedTech

Device Trial Radar · NCT06710626

Control of Assistive Devices Via Brain-Computer Interface Technology

CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

3

Planned (sponsor's estimate)

Start

Nov 25, 2024

Primary completion

May 25, 2031

Study completion May 25, 2031

Sponsor

Lead sponsor
Neuralink CorpNot on our public-company list
Sponsor type
Industry
First posted
Nov 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.

Conditions

  • Tetraplegia/Tetraparesis
  • Amyotrophic Lateral Sclerosis (ALS)
  • Quadriplegia
  • Spinal Cord Injury (SCI)
  • Spinal Cord Injury Cervical

Interventions

  • Assistive Robotic ArmDevice

    The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant.Time frame: 3-months following first use of the assistive device

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.